National Heart, Lung, and Blood Institute; Notice of Meeting, 61131 [2024-16680]
Download as PDF
Federal Register / Vol. 89, No. 146 / Tuesday, July 30, 2024 / Notices
Dated: July 24, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–16739 Filed 7–29–24; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Dental and
Oral Sciences.
Date: August 21, 2024.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Chee Lim, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4128, Bethesda, MD 20892,
(301) 435–1850, limc4@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 25,2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16720 Filed 7–29–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:51 Jul 29, 2024
Jkt 262001
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meeting of the National Asthma
Education Prevention Program
Coordinating Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/
watch=54913.
Name of Committee: National Asthma
Education Prevention Program Coordinating
Committee.
Date: September 23, 2024.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: Programmatic and Scientific
Updates.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20892,
https://videocast.nih.gov/watch=54913
(Virtual Meeting).
Contact Person: Mihaela Stefan, Ph.D.,
Program Director, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Bethesda, MD 20892,
301–435–4782, mihaela.stefan@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/advisory-and-peerreview-committees/national-asthmaeducation-andprevention-programcoordinating, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
61131
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 24, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16680 Filed 7–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend as well
as those who need special assistance,
such as sign language interpretation or
other reasonable accommodations, must
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://videocast.
nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5,
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council
(NANDSC).
Date: September 4–5, 2024.
Open: September 4, 2024, 10:00 a.m. to
5:00 p.m.
Agenda: Report by the Director, NINDS;
Report by the Acting Director, Division of
Extramural Activities; and Administrative
and Program Developments.
Open session will be videocast from this
link: https://videocast.nih.gov/.
Closed: September 5, 2024, 10:00 a.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications and the Division of Intramural
E:\FR\FM\30JYN1.SGM
30JYN1
Agencies
[Federal Register Volume 89, Number 146 (Tuesday, July 30, 2024)]
[Notices]
[Page 61131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16680]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of meeting of the National Asthma
Education Prevention Program Coordinating Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting can be accessed from the NIH
Videocast at the following link: https://videocast.nih.gov/watch=54913.
Name of Committee: National Asthma Education Prevention Program
Coordinating Committee.
Date: September 23, 2024.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: Programmatic and Scientific Updates.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20892, https://videocast.nih.gov/watch=54913 (Virtual
Meeting).
Contact Person: Mihaela Stefan, Ph.D., Program Director,
National Heart, Lung, and Blood Institute, National Institutes of
Health, 6705 Rockledge Drive, Bethesda, MD 20892, 301-435-4782,
[email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/national-asthma-education-andprevention-program-coordinating, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: July 24, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-16680 Filed 7-29-24; 8:45 am]
BILLING CODE 4140-01-P